Pricing Log in Create free account

Elicio Therapeutics, Inc. (ELTX) vs Kalaris Therapeutics Inc. (KLRS)

Elicio Therapeutics, Inc. and Kalaris Therapeutics Inc. are both Biotechnology companies. Elicio Therapeutics, Inc. and Kalaris Therapeutics Inc. are of similar size ($48.2M and $47.8M). Across the 9 metrics below, Kalaris Therapeutics Inc. leads on 8 and Elicio Therapeutics, Inc. on 1.

Valuation

Metric ELTX KLRS Biotechnology median
P/E n/m n/m 8.50
P/S 1.04 n/m 9.71
P/B 3.78 0.83 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.55 0.64
EV/Sales 0.59 n/m 9.21
Earnings yield (139.10%) (101.00%) (33.15%)
Free cash flow yield (125.90%) (85.89%) (25.50%)

Profitability

Metric ELTX KLRS Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (774.56%) (79.91%) (56.36%)
Return on assets (124.36%) (46.02%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ELTX KLRS Biotechnology median
Revenue growth (TTM) 921.02% — 6.02%
EPS growth (last fiscal year) 39.29% 94.50% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ELTX KLRS Biotechnology median
Debt to equity 1.20 0.00 0.00
Current ratio 2.77 10.98 4.72
Net debt to EBITDA 0.25 2.54 0.96

Dividend

Metric ELTX KLRS Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ELTX KLRS Biotechnology median
Market cap 48.22m 47.83m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack